New chikungunya vaccine shows promise in early trial
⭐️ VACCINE ⭐️
Completed
This study tested a new vaccine called HydroVax-005 CHIKV to see if it is safe and helps the body fight chikungunya virus, a mosquito-borne disease that causes fever and joint pain. 48 healthy adults aged 18 to 49 received two shots, either a low or high dose of the vaccine or a …
Phase: PHASE1 • Sponsor: Najit Technologies, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 11, 2026 20:49 UTC